Neurovascular/Interventional Neurology Market [AneurysmCoils, Carotid Stents, Microcatheter, Microguidewire, LiquidEmbolic Agents, & Cerebral Angioplasty Balloons] - GlobalTrends & Competitive Analysis to 2017Report Details:Published:October 2012No. of Pages: 234Price: Single User License – US$4650Neurointerventional radiology or endovascular neurosurgery refers to special minimally invasiveprocedures to diagnose and treat vascular disorders of the brain and spine. With the help ofadvanced imaging for guidance, neurointerventionalists or neurosurgeons use microcatheters (tinytubes) to treat many complex disorders. Normally these disorders are treated either by closing(embolization) or opening (recanalization) the abnormal vessels. The neurointerventional devicemarket encompasses neurothrombectomy devices (suction/aspiration device, clot retriever, andsnare device), cerebral angiography and stenting system (carotid stent, and embolic protectionsystem), aneurysm coiling devices (platinum coil, liquid embolic agents, and flow diversion device)and support devices (microcatheter, and microguidewire).The neurointerventional devices market encompasses neurothrombectomy devices(suction/aspiration device, clot retriever, and snare device), cerebral angiography and stentingsystem (carotid stent, and embolic protection system), aneurysm coiling devices (platinum coil,liquid embolic agents, and flow diversion device) and support devices (microcatheter, andmicroguidewire).The global neurointerventional devices market is estimated to be $1,248.5 million in 2012 and isexpected to grow at a CAGR of 6.8% to reach $1,733.7 million by 2017. Aneurysm Coiling &Arteriovenous Malformation Embolization & Fistula embolization segment accounts for the largestshare of the global neurointerventional devices market, followed by support devices cerebralballoon angioplasty & stenting systems and neurothrombectomy devices in 2012.The major driving factor for these markets involves gradual technological evolution, growingageing and obese population, rising patient pool for ischemic and hemorrhagic stroke andincreasing demand for minimally invasive surgical procedures. Growing GDP and healthcareallocation are making developing countries in Asia and Latin America affordable to adapt novel
medical practices for obtaining better treatment outcome. Upcoming clinical trial data is favoringthe interventional procedure over neurosurgery as it offers limited hospital stays, minimal damageto surrounding healthy tissues, lesser chances of infection in post-surgical phase, minimumsurgical trauma and lesser surgical scar.North America dominates the overall neurointerventional devices market. Asia-Pacific marketincluding India, China and Japan, and Latin America market are expected to grow at a higher pacedue to the effect of growing GDP and purchasing capability of healthcare institutions in thosecountries. Coiling procedure and flow diversion have gained popularity in the Asia-Pacific andLatin American market.The major players operating in the market are Covidien, PLC (Ireland), Stryker Corporation (U.S.),Johnson & Johnson (U.S.), and Penumbra, Inc. (U.S.).Scope of the ReportThis research report categorizes the neurointerventional device market for devices used inneurothrombectomy procedure, cerebral angiography and stenting technique, aneurysm coilingprocedure and support devices.Various neurointerventional devices are categorized into:•Neurothrombectomy procedure - Suction/aspiration device, clot retriever, and snare device•Cerebral angiography and stenting technique - Carotid stent, and embolic protection system•Aneurysm coiling procedure – Platinum coil (Bare & Coated), Liquid embolic agents, and Flow diversion device.•Support devices - Microcatheter and MicroguidewireGet your copy of this report @http://www.reportsnreports.com/reports/203750-neurovascular-interventional-neurology-market-aneurysm-coils-carotid-stents-microcatheter-microguidewire-liquid-embolic-agents-cerebral-angioplasty-balloons-global-trends-competitive-analysis-to-2017.htmlMajor points covered in Table of Contents of this report includeTable Of Contents1 INTRODUCTION1.1 KEY TAKE-AWAYS1.2 REPORT DESCRIPTION1.3 MARKETS COVERED1.4 STAKEHOLDERS1.5 RESEARCH METHODOLOGY1.5.1 MARKET SIZE1.5.2 MARKET SHARE1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES1.5.5 ASSUMPTIONS2 EXECUTIVE SUMMARY3 MARKET OVERVIEW3.1 INTRODUCTION3.2 MARKET SEGMENTATION3.3 MARKET DYNAMICS3.3.1 DRIVERS188.8.131.52 Advancements in technology184.108.40.206 Increasing aging & obese population220.127.116.11 Increasing number of ischemic & hemorrhagic stroke patients18.104.22.168 Growing demand for minimally invasive surgery3.3.2 RESTRAINTS22.214.171.124 Increasing complexity in clinical trials126.96.36.199 Decreasing average selling prices188.8.131.52 Hospital budget constraints& alternative treatment facilities3.3.3 THREATS & OPPORTUNITIES3.4 TRENDS3.5 UPCOMING TECHNOLOGIES3.6 MARKET SHARE ANALYSIS4 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET, BY TECHNIQUES4.1 INTRODUCTION4.2 NEUROTHROMBECTOMY4.3 CAROTID ARTERY ANGIOGRAPHY & STENTING4.4 EMBOLIZATION OF ARTERIOVENOUS MALFORMATION ARTERIOVENOUS FISTULA4.5 COILING PROCEDURE5 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCTS5.1 NEUROTHROMBECTOMY DEVICES5.1.1 INTRODUCTION5.1.2 SUCTION/ASPIRATION DEVICES5.1.3 CLOT RETRIEVER5.1.4 SNARE5.2 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS5.2.1 INTRODUCTION5.2.2 CAROTID ARTERY STENTS5.2.3 EMBOLIC PROTECTION SYSTEMS184.108.40.206 Distal filter devices220.127.116.11 Balloon occlusion devices
5.3 ANEURYSM COILING & ARTERIOVENOUS MALFORMATION EMBOLIZATION & FISTULAEMBOLIZATION5.3.1 INTRODUCTION5.3.2 EMBOLIC COIL18.104.22.168 Bare Platinum Detachable Coil22.214.171.124 Coated Detachable Coil5.3.3 LIQUID EMBOLIC AGENTS5.3.4 FLOW DIVERSION DEVICE5.4 SUPPORT DEVICES5.4.1 INTRODUCTION5.4.2 MICROCATHETER5.4.3 MICROGUIDEWIRE6 GEOGRAPHIC ANALYSIS6.1 INTRODUCTION6.2 NORTH AMERICA6.3 EUROPE6.4 ASIA6.5 REST OF THE WORLD (ROW)7 COMPETITIVE LANDSCAPE7.1 MERGERS & ACQUISITIONS7.2 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, JOINT VENTURES7.3 NEW PRODUCT LAUNCH7.4 APPROVAL7.5 EXPANSION7.6 OTHER DEVELOPMENTS8 COMPANY PROFILES8.1 ABBOTT LABORATORIES8.1.1 OVERVIEW8.1.2 FINANCIALS8.1.3 PRODUCTS & SERVICES8.1.4 STRATEGY8.1.5 DEVELOPMENTS8.2 BAYER AG8.2.1 OVERVIEW8.2.2 FINANCIAL8.2.3 PRODUCTS & SERVICES8.2.4 STRATEGY8.2.5 DEVELOPMENTS8.3 COAXIA, INC.